Toggle Main Menu Toggle Search

Open Access padlockePrints

Mitochondrial DNA pathogenic variant prevalence in primary mitochondrial disease patients with African (L) mitochondrial genome haplogroups

Lookup NU author(s): Dr Joanna ElsonORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

Primary mitochondrial diseases (PMD) are caused by pathogenic variants in over 350 genes, 37 of which are located in mitochondrial DNA (mtDNA). While more than 100 mtDNA variants have confirmed disease associations, there are few reports of mtDNA-related PMD in patients with African heritage, even in well-studied populations. We investigated the frequency of pathogenic mtDNA variants in African L-haplogroups in patients with confirmed PMD from two diagnostic cohorts. Data from genetically confirmed mtDNA-related cases were extracted from existing databases at the National Health Laboratory Service Inherited Metabolic Disease Laboratory in South Africa (SA), and the Children’s Hospital of Philadelphia (CHOP) Mitochondrial Medicine Frontier Program (USA). Mitochondrial genome haplogroup context was recorded from existing sequence report data. Stored DNA from the remaining cases was sequenced for mitochondrial genome haplogroup determination. Haplogroup context was obtained for 82 SA and 165 CHOP PMD cases. Sixty-two (47 SA; 15 USA) PMD cases from at least 50 maternal lineages were found to carry L Haplogroups. Unique L sub-haplogroups were identified in 11 (9 SA, 2 USA) families with the m.3243A>G MELAS variant, 6 SA families with the m.11778G>A LHON variant, and 20 (15 SA, 5 USA) cases with single large-scale mtDNA deletions (4 of whom had the 4,977 bp common deletion). Several additional well-documented mtDNA pathogenic variants were identified in L-haplogroup context. PMD patient clinical features correlated closely with those described in other haplogroup cohorts. This study demonstrates that common pathogenic mtDNA variants occur in the context of multiple African mtDNA lineages. Disproportionately low diagnostic rates highlight ongoing diagnostic inequalities affecting those on the African continent and African patients globally. Take home message: Common pathogenic mtDNA variants causal of PMD occur in the context of African mtDNA genome haplogroup lineages, while persisting diagnostic inequalities contribute to underdiagnosis of primary mitochondrial disease.


Publication metadata

Author(s): Meldau S, McCormick EM, George-Sanko I, Riordan GT, Khan K, MacMullen LE, Dawlat S, Blackhurst D, Falk MJ, Elson JL

Publication type: Article

Publication status: Published

Journal: JIMD Reports

Year: 2025

Volume: 66

Issue: 4

Online publication date: 11/07/2025

Acceptance date: 24/06/2025

Date deposited: 29/05/2025

ISSN (electronic): 2192-8312

Publisher: John Wiley & Sons Ltd

URL: https://doi.org/10.1002/jmd2.70036

DOI: 10.1002/jmd2.70036

Data Access Statement: The data that support the findings of this study are not publicly available due to privacy or ethical restrictions.


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
203105/Z/16/ZWellcome Trust
Children’s Hospital of Philadelphia Mitochondrial Medicine Frontier Program
National Health Laboratory Service. Grant Number: NHLSRT PR2117860
Warren Alpert Foundation

Share